Clindamycin/tretinoin - Dr. Reddys Laboratories

Drug Profile

Clindamycin/tretinoin - Dr. Reddys Laboratories

Alternative Names: Tretinoin/clindamycin- Dr. Reddys Laboratories

Latest Information Update: 09 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dr Reddys Laboratories
  • Class Antiacnes; Antibacterials; Keratolytics; Lincosamides; Retinoids; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Acne vulgaris

Most Recent Events

  • 09 Mar 2018 Dr. Reddys Laboratories completes a phase III trial in Acne vulgaris in India (Topical) (CTRI2014-08-004830), before March 2018
  • 08 Sep 2014 Phase-III clinical trials in Acne vulgaris in India (Topical) (CTRI2014-08-004830)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top